slas 2022 News

AGTC CEO to present at Cell & Gene Meeting on the Mesa

By The Science Advisory Board staff writers
October 12, 2021

Biotechnology firm Applied Genetic Technologies (AGTC) President and CEO Sue Washer will present at the Cell & Gene Meeting on the Mesa in Carlsbad, CA, on October 13 at 11:15 a.m. PT.

AGTC conducts human clinical trials of adeno-associated virus-based gene therapies for the treatment of rare inherited retinal diseases.

Washer will provide a corporate update and talk about AGTC's plans to move late-stage X-linked retinitis pigmentosa and achromatopsia clinical programs forward, the company said.

AGTC expands gene therapy manufacturing capabilities
Applied Genetic Technologies (AGTC) has initiated plans to lease a build-to-suit 21,000-sq-ft current good manufacturing practice manufacturing and quality...
AGTC touts positive early clinical results for gene therapy
Applied Genetic Technologies (AGTC) has reported positive data from its ongoing phase I/II clinical trial evaluating its adeno-associated virus (AAV)-based...
Customized gene therapies successfully target rare eye diseases
Can gene therapies prove effective for the treatment of rare genetic diseases? One company may have found a solution that incorporates a high degree of...

Copyright © 2021

Last Updated np 10/15/2021 9:05:25 AM